SANA

Sana Biotechnology, Inc.

3.71 USD

Last updated Dec 8, 21:42 UTC

Yesterday HIGH

$3.96

Yesterday LOW

$3.84

52w HIGH

$8

52w LOW

$2.74

EPS

-0.41

PE

-9.05

Next Earnings

Mar 14, 2024

Overview News Government Trades

Sana Biotechnology, Inc. stock is up 11.08% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 December’s closed higher than November.

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus. SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

sana.com

Lisa Levin

Tue May 30, 2023

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
Lisa Levin

Tue May 30, 2023

Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Lisa Levin

Mon May 15, 2023

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Lisa Levin

Mon May 15, 2023

Sarepta Therapeutics, C3.ai, monday.com, And Other Big Stocks Moving Higher On Monday

U.S. stocks traded lower, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording gains in today’s session.
Happy Mohamed

Mon May 8, 2023

Sana Biotechnology Q1 EPS $(0.43) Beats $(0.49) Estimate

Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.49) by 12.24 percent. This is a 8.51 percent increase over losses of $(0.47) per share from
Happy Mohamed

Mon May 8, 2023

Sana Biotechnology Announces Preclinical Data Published In Nature Biotechnology Demonstrating Its Hypoimmune-Engineered Cells Escape Immune Detection And Survive While Remaining Fully Functional

Hypoimmune-modified allogeneic iPSCs evade immune response and rejection without immunosuppression in non-human primate model Long-term survival and immune evasion of hypoimmune-modified allogeneic iPSCs at least
Benzinga Insights

Tue May 2, 2023

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
richadhand@benzinga.com

Tue May 2, 2023

HC Wainwright & Co. Initiates Coverage On Sana Biotechnology with Neutral Rating

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Sana Biotechnology (NASDAQ:SANA) with a Neutral rating.
Ye Kuang

Thu Apr 13, 2023

Why Sana Biotechnology Shares Are Trading Higher Today

Sana Biotechnology (NASDAQ: SANA) shares are trading higher after the company announced the publication of a paper in Nature Communications on hypoimmune-modified allogeneic CD19-directed CAR T cells.
Lisa Levin

Thu Apr 13, 2023

Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.